Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice

Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors (PAC1, VPAC) are present in sensory neurons and vascular smooth muscle. PACAP infusion was found to trigger migraine-like headache in humans and we showed its central pro-nociceptive function in several mouse pain models. N...

Full description

Bibliographic Details
Main Authors: Adrienn Markovics, Viktoria Kormos, Balazs Gaszner, Arvin Lashgarara, Eva Szoke, Katalin Sandor, Krisztina Szabadfi, Bernadett Tuka, Janos Tajti, Janos Szolcsanyi, Erika Pinter, Hitoshi Hashimoto, Jozsef Kun, Dora Reglodi, Zsuzsanna Helyes
Format: Article
Language:English
Published: Elsevier 2012-01-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996111003421
id doaj-af168d60755641929d761c3edfb1b7ff
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Adrienn Markovics
Viktoria Kormos
Balazs Gaszner
Arvin Lashgarara
Eva Szoke
Katalin Sandor
Krisztina Szabadfi
Bernadett Tuka
Janos Tajti
Janos Szolcsanyi
Erika Pinter
Hitoshi Hashimoto
Jozsef Kun
Dora Reglodi
Zsuzsanna Helyes
spellingShingle Adrienn Markovics
Viktoria Kormos
Balazs Gaszner
Arvin Lashgarara
Eva Szoke
Katalin Sandor
Krisztina Szabadfi
Bernadett Tuka
Janos Tajti
Janos Szolcsanyi
Erika Pinter
Hitoshi Hashimoto
Jozsef Kun
Dora Reglodi
Zsuzsanna Helyes
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
Neurobiology of Disease
Light-aversive behavior
Light–dark box
Laser Doppler blood perfusion scanning
Meningeal microcirculation
c-Fos immunohistochemistry
PAC1 receptor immunohistochemistry
author_facet Adrienn Markovics
Viktoria Kormos
Balazs Gaszner
Arvin Lashgarara
Eva Szoke
Katalin Sandor
Krisztina Szabadfi
Bernadett Tuka
Janos Tajti
Janos Szolcsanyi
Erika Pinter
Hitoshi Hashimoto
Jozsef Kun
Dora Reglodi
Zsuzsanna Helyes
author_sort Adrienn Markovics
title Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
title_short Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
title_full Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
title_fullStr Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
title_full_unstemmed Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
title_sort pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2012-01-01
description Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors (PAC1, VPAC) are present in sensory neurons and vascular smooth muscle. PACAP infusion was found to trigger migraine-like headache in humans and we showed its central pro-nociceptive function in several mouse pain models. Nitroglycerol (NTG)-induced pathophysiological changes were investigated in this study in PACAP gene-deleted (PACAP−/−) and wildtype (PACAP+/+) mice. Chemical activation of the trigeminovascular system was induced by 10 mg/kg i.p. NTG. Light-aversive behavior was determined in a light–dark box, meningeal microcirculation by laser Doppler blood perfusion scanning and the early neuronal activation marker c-Fos with immunohistochemistry. NTG-induced photophobia both in the early (0–30 min) and late phases (90–120 min) due to direct vasodilation and trigeminal sensitization, respectively, was significantly reduced in PACAP−/− mice. Meningeal blood flow increased by 30–35% during 4 h in PACAP+/+ mice, but only a 5–10% elevation occurred from the second hour in PACAP−/− ones. The number of c-Fos expressing cells referring to neuronal activation in the trigeminal ganglia and nucleus caudalis significantly increased 4 h after NTG in PACAP+/+, but not in PACAP−/− animals. Similar PAC1 receptor immunostaining was detected in both groups, which did not change 4 h after NTG treatment. PACAP-38 (300 μg/kg, i.p.) produced photophobia similarly to NTG and 30% meningeal vasodilatation for 30 min in PACAP+/+, but not in PACAP−/− mice. It significantly increased neural activation 4 h later in the trigeminal ganglia of both groups, but in the nucleus caudalis of only the PACAP+/+ mice.We provide the first experimental results that PACAP is a pivotal mediator of trigeminovascular activation/sensitization and meningeal vasodilation related to migraine.
topic Light-aversive behavior
Light–dark box
Laser Doppler blood perfusion scanning
Meningeal microcirculation
c-Fos immunohistochemistry
PAC1 receptor immunohistochemistry
url http://www.sciencedirect.com/science/article/pii/S0969996111003421
work_keys_str_mv AT adriennmarkovics pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT viktoriakormos pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT balazsgaszner pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT arvinlashgarara pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT evaszoke pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT katalinsandor pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT krisztinaszabadfi pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT bernadetttuka pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT janostajti pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT janosszolcsanyi pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT erikapinter pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT hitoshihashimoto pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT jozsefkun pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT dorareglodi pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
AT zsuzsannahelyes pituitaryadenylatecyclaseactivatingpolypeptideplaysakeyroleinnitroglycerolinducedtrigeminovascularactivationinmice
_version_ 1724208611361554432
spelling doaj-af168d60755641929d761c3edfb1b7ff2021-03-22T12:37:42ZengElsevierNeurobiology of Disease1095-953X2012-01-01451633644Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in miceAdrienn Markovics0Viktoria Kormos1Balazs Gaszner2Arvin Lashgarara3Eva Szoke4Katalin Sandor5Krisztina Szabadfi6Bernadett Tuka7Janos Tajti8Janos Szolcsanyi9Erika Pinter10Hitoshi Hashimoto11Jozsef Kun12Dora Reglodi13Zsuzsanna Helyes14Department of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., Hungary; Department of Anatomy, PTE-MTA Lendulet PACAP Research Group, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Anatomy, PTE-MTA Lendulet PACAP Research Group, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Experimental Zoology and Neurobiology, University of Pecs, H-7624 Pecs, Faculty of Natural Sciences, Ifjusag u. 6., HungaryNeurology Department, University of Szeged, Faculty of Medicine, H-6725, Szeged, Semmelweis u. 6., HungaryNeurology Department, University of Szeged, Faculty of Medicine, H-6725, Szeged, Semmelweis u. 6., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., Hungary; PharmInVivo Ltd., H-7629, Pecs, Szondi Gy. u. 10., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., Hungary; PharmInVivo Ltd., H-7629, Pecs, Szondi Gy. u. 10., HungaryLaboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan; Center for Child Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University and Hamamatsu University School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan; Department of Molecular Pharmaceutical Science, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, JapanDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Anatomy, PTE-MTA Lendulet PACAP Research Group, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., HungaryDepartment of Pharmacology and Pharmacotherapy, University of Pecs, Faculty of Medicine, H-7624, Pecs, Szigeti u. 12., Hungary; PharmInVivo Ltd., H-7629, Pecs, Szondi Gy. u. 10., Hungary; Corresponding author at: Department of Pharmacology and Pharmacotherapy, University of Pécs, Pécs-7624, Szigeti u. 12., Hungary. Fax: +36 72 536218.Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors (PAC1, VPAC) are present in sensory neurons and vascular smooth muscle. PACAP infusion was found to trigger migraine-like headache in humans and we showed its central pro-nociceptive function in several mouse pain models. Nitroglycerol (NTG)-induced pathophysiological changes were investigated in this study in PACAP gene-deleted (PACAP−/−) and wildtype (PACAP+/+) mice. Chemical activation of the trigeminovascular system was induced by 10 mg/kg i.p. NTG. Light-aversive behavior was determined in a light–dark box, meningeal microcirculation by laser Doppler blood perfusion scanning and the early neuronal activation marker c-Fos with immunohistochemistry. NTG-induced photophobia both in the early (0–30 min) and late phases (90–120 min) due to direct vasodilation and trigeminal sensitization, respectively, was significantly reduced in PACAP−/− mice. Meningeal blood flow increased by 30–35% during 4 h in PACAP+/+ mice, but only a 5–10% elevation occurred from the second hour in PACAP−/− ones. The number of c-Fos expressing cells referring to neuronal activation in the trigeminal ganglia and nucleus caudalis significantly increased 4 h after NTG in PACAP+/+, but not in PACAP−/− animals. Similar PAC1 receptor immunostaining was detected in both groups, which did not change 4 h after NTG treatment. PACAP-38 (300 μg/kg, i.p.) produced photophobia similarly to NTG and 30% meningeal vasodilatation for 30 min in PACAP+/+, but not in PACAP−/− mice. It significantly increased neural activation 4 h later in the trigeminal ganglia of both groups, but in the nucleus caudalis of only the PACAP+/+ mice.We provide the first experimental results that PACAP is a pivotal mediator of trigeminovascular activation/sensitization and meningeal vasodilation related to migraine.http://www.sciencedirect.com/science/article/pii/S0969996111003421Light-aversive behaviorLight–dark boxLaser Doppler blood perfusion scanningMeningeal microcirculationc-Fos immunohistochemistryPAC1 receptor immunohistochemistry